News By Tag
News By Place
Dr. H. Vijay of VLN Biotechnology Contributes to 5th Edition of Allergens and Allergy Immunotherapy
VLN Biotechnology - a Company focused on development of immunotherapy against the common allergenic molds Alternaria & Cladosporium
Dr. Vijay’s chapter is entitled “Fungal Allergens” (Chapter 12) and reviews many of the common indoor and outdoor fungus and mold allergens. The chapter was co-authored with colleagues Dr. Viswanath Kurup (Medical College of Wisconsin) & Dr. Jonathan Bernstein (University of Cincinnati).
The American College of Occupational and Environmental Medicine (http://www.acoem.org/
VLNB seeks to partner with companies and research organizations to accelerate commercial development of immunotherapy to treat mold allergies. VLNB also offers customized consulting services led by Dr. Hari Vijay.
About VLN Biotechnology
VLN Biotechnology is commercializing immunotherapy technology to improve the health and quality of life of patients suffering from allergies to mold. We are focused on improved detection of allergenic proteins responsible for allergic reactions and development of immunotherapy to alleviate symptoms of mold allergies. VLN Biotechnology was founded by Dr. Hari Vijay, an acknowledged global expert on mold allergens. For further information please visit www.vln-biotech.com.
VLN Biotechnology Inc.
5303 Canotek Road
Ottawa, ON K1J 9M2